Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning

被引：31
|
作者：
Askaa, B. [1 ]
Fischer-Nielsen, A. [2 ]
Vindelov, L. [1 ]
Haastrup, E. K. [2 ]
Sengelov, H. [1 ]
机构：
[1] Natl Univ Hosp, Dept Hematol, Copenhagen, Denmark
[2] Natl Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷 / 05期
关键词：
BLOOD-CELLS; FAILURE; MARROW;
D O I：
10.1038/bmt.2014.5
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：720 / 721
页数：2
相关论文
共 50 条
  • [41] CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease
    Hemalatha G. Rangarajan
    Sara A. Crowell
    Alison S. Towerman
    Shalini S. Shenoy
    Bone Marrow Transplantation, 2022, 57 : 1592 - 1594
  • [42] CD34+-Selected Infusions of Fresh or Cryopreserved Peripheral Blood Stem Cells for the Treatment of Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplant
    Ghobadi, Armin
    Fiala, Mark A.
    Ramsingh, Giridharan
    Gao, Feng
    Abboud, Camille N.
    Stockerl-Goldstein, Keith
    Uy, Geoffrey L.
    Westervelt, Peter
    DiPersio, John F.
    BLOOD, 2015, 126 (23)
  • [43] Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
    Servais, Sophie
    Baron, Frederic
    Lechanteur, Chantal
    Seidel, Laurence
    Baudoux, Etienne
    Briquet, Alexandra
    Selleslag, Dominik
    Maertens, Johan
    Poire, Xavier
    Schroyens, Wilfried
    Graux, Carlos
    De Becker, Ann
    Zachee, Pierre
    Ory, Aurelie
    Herman, Julie
    Kerre, Tessa
    Beguin, Yves
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [44] Rituximab Use, Immune Reconstitution, and Vaccination after Ex-Vivo CD34-Selected Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)
    Preston, Elaina V.
    Malard, Florent
    Seier, Kenneth
    Cho, Christina
    Devlin, Sean M.
    Maloy, Molly
    Borrill, Taylor
    Palazzo, Meighan
    Smith, Katherine
    Maslak, Peter
    van den Brink, Marcel R. M.
    Shah, Gunjan L.
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S360 - S361
  • [45] Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation
    Rondon-Clavo, Carlos
    Scordo, Michael
    Hilden, Patrick
    Shah, Gunjan L.
    Cho, Christina
    Maloy, Molly A.
    Papadopoulos, Esperanza B.
    Jakubowski, Ann A.
    O'Reilly, Richard J.
    Gyurkocza, Boglarka
    Castro-Malaspina, Hugo
    Tamari, Roni
    Shaffer, Brian C.
    Perales, Miguel-Angel
    Jaimes, Edgar A.
    Giralt, Sergio A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (12) : 2517 - 2522
  • [46] Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation
    Davies, Jeff K.
    Brennan, Lisa L.
    Wingard, John R.
    Cogle, Christopher R.
    Kapoor, Neena
    Shah, Ami J.
    Dey, Bimalangshu R.
    Spitzer, Thomas R.
    de Lima, Marcos
    Cooper, Laurence J.
    Thall, Peter F.
    Champlin, Richard E.
    Nadler, Lee M.
    Guinan, Eva C.
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4098 - 4109
  • [47] ELTROMBOPAG IS AN EFFECTIVE TREATMENT OF POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A GITMO SURVEY
    Faraci, Maura
    Pierri, Filomena
    Sica, Simona
    Giammarco, Sabrina
    Musso, Maurizio
    Crescimanno, Alessandra
    Biffi, Alessandra
    Calore, Elisabetta
    Benedetti, Fabio
    Montagnoli, Martina
    Cerretti, Raffaella
    Iori, Anna Paola
    Cavattoni, Irene Maria
    Fagioli, Franca
    Saglio, Francesco
    Cuoghi, Angela
    Prete, Arcangelo
    Borghero, Carlo
    Tintori, Veronica
    Sanvito, Maria Chiara
    Tambaro, Francesco Paolo
    Bramanti, Stefania
    Skert, Cristina
    Porto, Gaetana
    Mordini, Nicola
    Piccardi, Alessandra
    Merli, Francesco
    Facchini, Luca
    Pane, Fabrizio
    Battipaglia, Giorgia
    Pelosini, Matteo
    Menconi, Maria Cristina
    Serio, Bianca
    Giudice, Valentina
    Cimminiello, Michele
    Degrandi, Eliana
    Gheorghiu, Angela
    Martino, Massimo
    Ciceri, Fabio
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 509 - 510
  • [48] CD34+ Cells in Bone Marrow Are Quantitatively and Functionally Impaired in Patients with Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation
    Kong, Yuan
    Hu, Yue
    Zhang, Yuan-yuan
    Chen, Yu-Hong
    Han, Wei
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Huang, Xiao-Jun
    BLOOD, 2014, 124 (21)
  • [49] Correction to: CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease
    Hemalatha G. Rangarajan
    Sara A. Crowell
    Alison S. Towerman
    Shalini S. Shenoy
    Bone Marrow Transplantation, 2022, 57 : 1855 - 1855
  • [50] Increased Levels of Reactive Oxygen Species and Exhaustion of the Quiescent CD34+ Cells May Operate in Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Kong, Yuan
    Hu, Yue
    Song, Yang
    Wang, Yu-Tong
    Jiang, Zheng-Fan
    Deng, Hong-Kui
    Huang, Xiao Jun
    BLOOD, 2015, 126 (23)
12345